We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 7,079 results
  1. Chemical composition and antifungal activity of Teucrium Leucocladum Boiss. essential oils growing in Egypt using two different techniques

    Background

    Teucrium Leucocladum Boiss. (TL) (family Lamiaceae), indigenous to Sinai, Egypt, and Mediterranean region, is considered a rich source of...

    Eman Mohamed Salah, Marwa Y. Issa, ... Noha Fathallah in Future Journal of Pharmaceutical Sciences
    Article Open access 28 March 2024
  2. Elucidating the antifungal activity and mechanism of action of bioactive phytochemicals against fungal dermatitis isolates

    Dermatophytosis has been the most common cause of superficial fungal infections which invade the keratinized tissues of body such as nail, hair, and...

    Tanya Bhayana, Sarika Gupta in Archives of Dermatological Research
    Article 27 November 2022
  3. Exploring the Potential of Farnesol as a Novel Antifungal Drug and Related Challenges

    Purpose of Review

    Farnesol (FOH) is a quorum-sensing molecule with potential as an antifungal drug. Given the growing concern about fungal drug...

    Dongming Zheng, Linlan Yang, ... Yan Li in Current Infectious Disease Reports
    Article 26 February 2024
  4. Antifungal Stewardship Interventions in Patients with Hematologic Malignancies

    Purpose of Review

    Antifungal stewardship has been recognized as a significant component of any antimicrobial stewardship program. In this article, we...

    Paschalis Vergidis, Ryan W. Stevens, Samir G. Agrawal in Current Fungal Infection Reports
    Article Open access 24 May 2023
  5. Antifungal therapy for the treatment of CNS infections

    Purpose of review

    A review of existing and emerging therapies for the treatment of fungal infections of the CNS is presented, highlighting more recent...

    Moeen Aboabdo, Aaron Mishkin in Current Fungal Infection Reports
    Article 16 March 2024
  6. Candida albicans and Antifungal Peptides

    Candida albicans , a ubiquitous opportunistic fungal pathogen, plays a pivotal role in human health and disease. As a commensal organism, it normally...

    Camila G. Freitas, Maria Sueli Felipe in Infectious Diseases and Therapy
    Article Open access 08 November 2023
  7. Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases

    Background

    The severe fever with thrombocytopenia syndrome disease (SFTS), caused by the novel tick-borne SFTS virus (SFTSV), was listed among the top...

    Shu Shen, Yaxian Zhang, ... Fei Deng in BMC Medicine
    Article Open access 21 October 2022
  8. Antifungal activity of three different varieties of Capsicum annuum against clinical isolates of Candida species

    Objective

    Acquired resistance to antifungal agents is rising among Candida species. Herbal extracts including Capsicum annum extracts have biological...

    Shaghayegh Moghadam, Behnam Azari, ... Hossein Zarrinfar in Tropical Diseases, Travel Medicine and Vaccines
    Article Open access 20 July 2023
  9. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation

    Extracorporeal membrane oxygenation (ECMO) is an established advanced life support system, providing temporary cardiac and/or respiratory support in...

    Haifa Lyster, Kiran Shekar, ... Mohd-Hafiz Abdul-Aziz in Clinical Pharmacokinetics
    Article Open access 10 June 2023
  10. Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

    Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis observed in critically ill patients. It is associated with high...

    Emmanuel Novy, Claire Roger, ... Menino Osbert Cotta in Critical Care
    Article Open access 20 November 2023
  11. Role of Antifungal Susceptibility Tests in the Treatment of Vulvovaginal Candidiasis

    Purpose of Review

    The increased prevalence of antifungal drug resistance associated with common vaginal pathogen C. albicans as well as non- albicans...

    Article 22 February 2023
  12. Characterization of tea (Camellia sinensis L.) flower extract and insights into its antifungal susceptibilities of Aspergillus flavus

    Background

    Tea ( Camellia sinensis L.) flowers will compete with tea leaves in nutrition and are abandoned as an undesirable by-product. In this...

    Fangfang Chen, Yu-Pei Chen, ... Jeng-Yuan Yao in BMC Complementary Medicine and Therapies
    Article Open access 14 August 2023
  13. Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review

    Antifungal drug development is essential as invasive fungal disease is still associated with a very high mortality rate and the emergence of...

    Theresa Pecho, Markus Zeitlinger in Clinical Pharmacokinetics
    Article Open access 16 November 2023
  14. Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.

    Background

    Oral candidiasis is an opportunistic disease caused by fungi of the Candida genus. The occurrence of Candida spp. resistance to the...

    Ana Rita Sokolonski, Maísa Santos Fonseca, ... Ricardo W. Portela in BMC Complementary Medicine and Therapies
    Article Open access 24 November 2021
  15. Antifungal Resistance and the Role of New Therapeutic Agents

    Purpose of Review

    Advances in health care over time have led to an evolution in the epidemiology of invasive fungal infections. There is an increasing...

    Ashley Logan, Amanda Wolfe, John C. Williamson in Current Infectious Disease Reports
    Article 05 July 2022
  16. A case of Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim

    Purpose

    To report a case of endogenous Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim.

    Case report ...
    Michael Dong, Fiona Pearce, ... Ming-Lee Lin in Journal of Ophthalmic Inflammation and Infection
    Article Open access 22 March 2024
  17. Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia

    Purpose of Review

    This review will provide an overview of the potential drug-drug interactions (DDIs) that may occur when using small-molecule kinase...

    Russell E. Lewis, Marta Stanzani in Current Fungal Infection Reports
    Article Open access 27 July 2023
  18. Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa

    Purpose of Review

    Azole resistance in Aspergillus fumigatus is an emerging public health issue with global distribution and has been linked to use in...

    Conrad Chibunna Achilonu, Adeyinka Davies, ... Rita Oladele in Current Treatment Options in Infectious Diseases
    Article Open access 19 December 2023
  19. Chemical profiling of antifungal Dicerocaryum senecioides and Diospyros mespiliformis extracts using TLC-p-iodonitrotetrazolium violet assay and GC–MS/MS

    Background

    Despite the availability of conventional medication for fungal skin diseases, dermatophytic infections are now a major crisis in the whole...

    R. Zhou, P. Dzomba, L. Gwatidzo in Future Journal of Pharmaceutical Sciences
    Article Open access 04 December 2023
  20. Design of a renal-sparing antifungal

    Susan J. Allison in Nature Reviews Nephrology
    Article 30 January 2024
Did you find what you were looking for? Share feedback.